4//SEC Filing
Harris Melody 4
Accession 0001077183-24-000002
CIK 0001077183other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:28 PM ET
Size
11.2 KB
Accession
0001077183-24-000002
Insider Transaction Report
Form 4
Harris Melody
Chf Ops Off, Pres, Informatics
Transactions
- Tax Payment
Common Stock
2024-01-01−7,123→ 102,955 total
Holdings
- 39,683
Stock Option (Right to Buy)
Exercise: $19.65Exp: 2030-05-11→ Common Stock (39,683 underlying) - 21,204
Restricted Stock Unit
Exercise: $0.00→ Common Stock (21,204 underlying) - 201,613
Stock Option (Right to Buy)
Exercise: $9.24Exp: 2030-01-01→ Common Stock (201,613 underlying) - 21,204
Performance Stock Unit
Exercise: $0.00From: 2026-05-11→ Common Stock (21,204 underlying)
Footnotes (7)
- [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the January 1, 2024 vesting of restricted stock.
- [F2]This balance includes 514 shares that were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
- [F3]On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F5]On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F6]Once vested, the shares of common stock are not subject to expiration.
- [F7]On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001880847
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:28 PM ET
- Size
- 11.2 KB